Tested Applications
| Positive IHC detected in | human malignant melanoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
27329-1-AP targets PMEL/Melanoma gp100 in IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag25796 Product name: Recombinant human PMEL/Melanoma gp100 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 470-595 aa of BC001414 Sequence: QVPLDCVLYRYGSFSVTLDIVQGIESAEILQAVPSGEGDAFELTVSCQGGLPKEACMEISSPGCQPPAQRLCQPVLPSPACQLVLHQILKGGSGTYCLNVSLADTNSLAVVSTQLIMPGQEAGLGQ Predict reactive species |
| Full Name | silver homolog (mouse) |
| Calculated Molecular Weight | 70 kDa |
| GenBank Accession Number | BC001414 |
| Gene Symbol | SILV |
| Gene ID (NCBI) | 6490 |
| RRID | AB_2880846 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P40967 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for PMEL/Melanoma gp100 antibody 27329-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The PMEL/Melanoma gp100 Polyclonal antibody (Cat# 27329-1-AP) has 1 total citation. It appears in the International Journal of Molecular Sciences (IF 5.6), in a study investigating how Pmel17 deficiency affects melanogenesis and promotes tumor vascularization. The research falls within the fields of melanocyte biology, pigmentation, and tumor angiogenesis, with the antibody applied in IHC on mouse samples.
| Species | Application | Title |
|---|---|---|
Int J Mol Sci Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization.
|



